Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Enze Kangtai
company
About
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biopharma,Biotechnology,Genetics,Medical
- Founded date
- Jun 1, 2017
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Enze Kangtai has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 11, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 11, 2022 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Enze Kangtai is funded by 1 investors.
Tigeryeah Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Tigeryeah Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
